Changes in Body Mass Index and Lipid Profile in Psoriatic Patients After Treatment With Standard Protocol of Infliximab

Changes in Body Mass Index and Lipid Profile in Psoriatic Patients After Treatment With Standard Protocol of Infliximab

Psoriasis is a chronic and inflammatory dermatologic disease. Psoriasis may predispose to cardiovascular disease and diabetes. However, the role of tumor necrosis factor (TNF) inhibitor in mediating this risk is controversial. Regarding frequent use of infliximab in psoriasis, and the hypothesis th...

Full description

Bibliographic Details
Main Authors: Amir Houshang Ehsani, Hossein Mortazavi, Kamran Balighi, Mahboubeh Sadat Hosseini, Arghavan Azizpour, Seyyedeh Pardis Hejazi, Azadeh Goodarzi, Seyyedeh Bahareh Darvari
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2016-10-01
Series:Acta Medica Iranica
Subjects:
Body mass index
Lipid profile
Psoriasis
Infliximab
Online Access:https://acta.tums.ac.ir/index.php/acta/article/view/5326

Internet

https://acta.tums.ac.ir/index.php/acta/article/view/5326

Similar Items